In vitro pharmacology means studies on the biological effects of drugs and pharmaceuticals, conducted outside of living organisms. Any new drug or pharmaceutical that enters the market is a product of a long and rigorous development, testing, and approval process. At the early stage of drug discovery, the most promising molecules ("leads") undergo further screening to generates high-quality data in a precise and timely manner. All these parameters including chemical's safety, toxicity, pharmacokinetics, and metabolism must be assessed in the pre-clinical trials phase.
MedAI offers a comprehensive selection of services to support your research needs in biology and In vitro pharmacology. Our experts are specializing in providing the broadest drug discovery portfolio of both standard and custom In vitro assays. Services for drug discovery binding and functional assays are listed below.
Kinase Enzymes Assays
Cytokine Receptors Assays
Growth Factor Receptors Assays
Nuclear Receptors Assays
Phosphatases & Proteases Assays
Epigenetic Proteins & Enzymes Assays
Ubiquitin Enzymes & Substrates Assays
MedAI provides customized technical solutions that can best meet your requirements, prerequisites, and objectives, with particular attention given to the feasibility study and personalized management of your projects, covering the whole process of drug discovery and development.
Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to email@example.com for inquiries.
Tech Trends in Artificial Intelligence What's up, what's down, what lies ahead, only found in MedAI!